Optimus Drugs Private Limited operates as a pharmaceutical company. The Company manufactures, fabricates, and processes drugs in pharmaceutical preparations for human or veterinary use. Optimus Drugs serves customers worldwide.
In India, the Pharmaceutical business of Synvina C.V. is focused on process for the preparation of Apixaban, industrial process for making an Ivacaftor and its intermediates, process for the preparation of linezolid, process for the preparation of linezolid.
Optimus Drugs (P) Ltd. filed patent application numbered 2583/CHE/2014 that is titled PROCESS FOR THE PREPARATION OF 5- PIPERAZIN-L-YL-BENZOFURAN-2-CARBOXYLIC ACID ETHYL ESTER. This Patent Application has been granted as as Patent number 316824.
The invention covers Chemical compound. This invention relates to an improved, commercially viable and industrially advantageous process of 5- piperazin-l-yl-benzofuran-2-carboxylic acid ethyl ester.
During patent examination, the patent examiner raised objections under Section 3(d) of the Indian Patents Act that the subject matter of claims 1, 3 are not allowed under section 3(d) of the Patents act as it relates to a known compounds or salts of known compounds.
As a response to the said objection, the applicant explained novelty in the scientific manner. Also that the present invention is of process only and not a composition/ combination and have no pharmaceutical value. These are brought to differentiate.
Advocate Rahul Dev is a Patent Attorney & International Business Lawyer practicing Technology, Intellectual Property & Corporate Laws. He is reachable at rd (at) patentbusinesslawyer (dot) com & @rdpatentlawyer on Twitter.
Quoted in and contributed to 50+ national & international publications (Bloomberg, FirstPost, SwissInfo, Outlook Money, Yahoo News, Times of India, Economic Times, Business Standard, Quartz, Global Legal Post, International Bar Association, LawAsia, BioSpectrum Asia, Digital News Asia, e27, Leaders Speak, Entrepreneur India, VCCircle, AutoTech).
Regularly invited to speak at international & national platforms (conferences, TV channels, seminars, corporate trainings, government workshops) on technology, patents, business strategy, legal developments, leadership & management.
